{"id":341024,"date":"2025-08-20T13:47:59","date_gmt":"2025-08-20T13:47:59","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-dexcom\/"},"modified":"2025-08-20T13:47:59","modified_gmt":"2025-08-20T13:47:59","slug":"how-to-buy-dexcom","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/","title":{"rendered":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"DexCom, Inc. (DXCM) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, 2025 tahminleri ve t\u0131bbi teknoloji sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ad\u0131m ad\u0131m rehber ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"DexCom, Inc. (DXCM) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, 2025 tahminleri ve t\u0131bbi teknoloji sekt\u00f6r\u00fcnde b\u00fcy\u00fcme arayan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in ad\u0131m ad\u0131m rehber ile \u00f6\u011frenin."},"intro":"H\u0131zla b\u00fcy\u00fcyen diyabet teknolojisi pazar\u0131na girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? DexCom, Inc. (DXCM), t\u0131bbi inovasyon dalgas\u0131na binmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor. S\u00fcrekli glikoz izleme sistemleriyle diyabet bak\u0131m\u0131n\u0131 d\u00fcnya \u00e7ap\u0131nda devrim niteli\u011finde de\u011fi\u015ftiren bu \u015firket, milyarlarca dolarl\u0131k bir end\u00fcstrinin \u00f6n saflar\u0131nda yer al\u0131yor. Mevcut hisse performans\u0131ndan 2025 i\u00e7in ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u0131zla b\u00fcy\u00fcyen diyabet teknolojisi pazar\u0131na girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? DexCom, Inc. (DXCM), t\u0131bbi inovasyon dalgas\u0131na binmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor. S\u00fcrekli glikoz izleme sistemleriyle diyabet bak\u0131m\u0131n\u0131 d\u00fcnya \u00e7ap\u0131nda devrim niteli\u011finde de\u011fi\u015ftiren bu \u015firket, milyarlarca dolarl\u0131k bir end\u00fcstrinin \u00f6n saflar\u0131nda yer al\u0131yor. Mevcut hisse performans\u0131ndan 2025 i\u00e7in ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 DexCom Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, DexCom, Inc. (DXCM) NASDAQ borsas\u0131nda <strong>80,90 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>23 Ekim 2025<\/strong> kesinlikle kritik - DexCom, piyasa kapan\u0131\u015f\u0131ndan sonra bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak.<\/p> <p>\u015eirket, 30 Temmuz'da g\u00fc\u00e7l\u00fc 2025 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 bildirdi; gelir y\u0131ll\u0131k %15 art\u0131\u015fla 1,16 milyar $'a y\u00fckseldi ve beklentileri 0,03 $ a\u015fan 0,48 $ hisse ba\u015f\u0131 kazan\u00e7 (EPS) a\u00e7\u0131klad\u0131. Tarihsel olarak, bu kazan\u00e7 raporlar\u0131 \u00f6nemli fiyat hareketlerine neden olur.<\/p> <p><strong>Kazan\u00e7 Raporlar\u0131 Genellikle DXCM Hissesini Nas\u0131l Etkiler:<\/strong><\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>30 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>78,50 $<\/td><td>%3,1 Art\u0131\u015f (1 hafta)<\/td><\/tr> <tr><td>30 Nis 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>75,20 $<\/td><td>%6,8 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>31 Oca 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>72,80 $<\/td><td>%4,2 Art\u0131\u015f (g\u00fc\u00e7l\u00fc rehberlik)<\/td><\/tr> <tr><td>24 Eki 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>68,90 $<\/td><td>%2,1 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>25 Tem 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>65,40 $<\/td><td>%5,3 Art\u0131\u015f (\u00fcr\u00fcn lansman\u0131)<\/td><\/tr> <tr><td>25 Nis 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>62,10 $<\/td><td>%8,7 Art\u0131\u015f (FDA onay haberi)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle DXCM'yi bir hafta i\u00e7inde %5-8 oran\u0131nda y\u00fckseltirken, beklentilerin alt\u0131nda kalan sonu\u00e7lar k\u0131sa vadede %2-3 d\u00fc\u015f\u00fc\u015fe neden olur. Hisse, pazar liderli\u011fi konumu nedeniyle g\u00fc\u00e7l\u00fc dayan\u0131kl\u0131l\u0131k ve h\u0131zl\u0131 toparlanma e\u011filimleri g\u00f6stermi\u015ftir.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2> <p>DexCom hisseleri son alt\u0131 ayda etkileyici volatilite ve b\u00fcy\u00fcme g\u00f6sterdi:<\/p> <p><strong>\u015eubat 2025<\/strong>: 72,50 $ (tatil sonras\u0131 konsolidasyon)<br> <strong>Mart 2025<\/strong>: 76,80 $ (G7 15 G\u00fcnl\u00fck FDA onay\u0131 beklentisi)<br> <strong>Nisan 2025<\/strong>: 79,20 $ (1. \u00e7eyrek kazan\u00e7lar\u0131 a\u015f\u0131m\u0131 + rehberlik y\u00fckseltmesi)<br> <strong>May\u0131s 2025<\/strong>: 81,50 $ (kurumsal birikim d\u00f6nemi)<br> <strong>Haziran 2025<\/strong>: 77,30 $ (piyasa genelinde teknoloji sekt\u00f6r\u00fc d\u00fczeltmesi)<br> <strong>Temmuz 2025<\/strong>: 82,40 $ (g\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131 + tam y\u0131l rehberli\u011fi y\u00fckseltildi)<br> <strong>A\u011fustos 2025<\/strong>: 80,90 $ (mevcut seviye, kazan\u00e7 sonras\u0131 konsolidasyon)<\/p> <p>Hisse bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%11,6<\/strong> de\u011fer kazand\u0131 ve bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fc rakibini \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. Bu b\u00fcy\u00fcme, ba\u015far\u0131l\u0131 \u00fcr\u00fcn lansmanlar\u0131, geni\u015fleyen sigorta kapsam\u0131 ve artan k\u00fcresel diyabet prevalans\u0131 gibi bir\u00e7ok kataliz\u00f6r taraf\u0131ndan desteklendi.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve piyasa trendlerine dayanarak, beklenenler \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 95-105 $ (mevcut seviyelerden %23-30 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br> Analistler ortalama 99,89 $ fiyat hedefi ile \"G\u00fc\u00e7l\u00fc Al\" derecesini koruyor, bu %23,48 potansiyel y\u00fckseli\u015fi temsil ediyor<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DXCM\/forecast\/\">MarketBeat<\/a><\/li> <li><strong>2026 Tahmini<\/strong>: 105-115 $ (%30-42 toplam kazan\u00e7)<br> Morgan Stanley'nin 89,00 $'a y\u00fckseltti\u011fi hedef, temkinli b\u00fcy\u00fcmeyi i\u015faret ederken di\u011fer analistler 100 $+ seviyelerini \u00f6ng\u00f6r\u00fcyor<a href=\"https:\/\/www.ainvest.com\/news\/dexcom-price-target-raised-morgan-stanley-89-00-maintains-equal-weight-rating-2507\/\">AInvest<\/a><\/li> <li><strong>2028 Projeksiyonu<\/strong>: 120-140 $ (%48-73 de\u011fer art\u0131\u015f\u0131)<br> K\u00fcresel diyabet salg\u0131n\u0131 ve geli\u015fmekte olan pazarlarda teknoloji benimsenmesi taraf\u0131ndan destekleniyor<\/li> <li><strong>2030 Uzun Vadeli<\/strong>: 150-180 $ (%85-122 toplam getiri)<br> CGM pazar\u0131n\u0131n 2035'e kadar 12,8 milyar dolardan 55 milyar dolara geni\u015flemesine dayan\u0131yor<a href=\"https:\/\/www.futuremarketinsights.com\/reports\/continuous-glucose-monitoring-systems-market\">Future Market Insights<\/a><\/li> <\/ul>  <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li> <li><strong>Rekabet yo\u011funlu\u011fu<\/strong>: Abbott'un FreeStyle Libre ve Medtronic sistemleri g\u00fc\u00e7l\u00fc rakiplerdir<\/li> <li><strong>Geri \u00f6deme de\u011fi\u015fiklikleri<\/strong>: Sigorta kapsam\u0131 politikalar\u0131 benimsenme oranlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiler<\/li> <li><strong>Y\u00fcksek de\u011ferleme<\/strong>: 56,51 P\/E oran\u0131 primli fiyatlamay\u0131 g\u00f6sterir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>%15 gelir b\u00fcy\u00fcmesi<\/strong>: 2025 2. \u00e7eyrek g\u00fc\u00e7l\u00fc geni\u015fleme g\u00f6sterdi<a href=\"https:\/\/stockinvest.us\/DXCM-stock-price\">StockInvest<\/a><\/li> <li><strong>Kurumsal birikim<\/strong>: Fox Run Management ve Corient IA pozisyonlar\u0131n\u0131 art\u0131r\u0131yor<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DXCM\/news\/\">MarketBeat Haberleri<\/a><\/li> <li><strong>Pazar liderli\u011fi<\/strong>: G7 15 G\u00fcnl\u00fck sistemi \"en do\u011fru CGM\" olarak FDA onay\u0131 ald\u0131<a href=\"https:\/\/investors.dexcom.com\/news\/news-details\/2025\/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System\/default.aspx\">DexCom Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a><\/li> <li><strong>K\u00fcresel diyabet b\u00fcy\u00fcmesi<\/strong>: D\u00fcnya genelinde 537 milyon yeti\u015fkin diyabetli ve bu say\u0131 her y\u0131l art\u0131yor<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 temsil etmeyen pozisyonlarla ba\u015flay\u0131n<\/li> <li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Toplu al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 23 Ekim kazan\u00e7 tarihi \u00e7evresinde fiyat hareketlerini takip edin<\/li> <li><strong>Uygun \u015fekilde \u00e7e\u015fitlendirin<\/strong>: DXCM, di\u011fer sa\u011fl\u0131k ve teknoloji hisseleriyle dengelenmeli<\/li> <\/ol> <p>Esprili yat\u0131r\u0131mc\u0131 bilgeli\u011fi: \"DXCM ticareti yapmak, diyabeti y\u00f6netmek gibidir - s\u00fcrekli izleme ve ara s\u0131ra d\u00fczeltmeler gerekir, ancak uzun vadeli trend kesinlikle tatl\u0131d\u0131r!\"<\/p>  <h2>\u2705 DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve temel finansal bilgi ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"DXCM\" aramas\u0131 yap\u0131n<\/td><td>Sadece \"DexCom\" de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri giri\u015f fiyat\u0131n\u0131 kontrol etmeye yard\u0131mc\u0131 olur, piyasa emirlerine kar\u015f\u0131<\/td><\/tr> <tr><td>6<\/td><td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti onaylamadan \u00f6nce kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td><td>Pozisyonu izleyin ve uygun stop-loss seviyeleri belirleyin<\/td><\/tr> <tr><td>8<\/td><td>Performans\u0131 takip edin<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131n\u0131 kullan\u0131n<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Neden Pocket Option Yeni DXCM Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, DXCM hisseleri ticareti konusunda birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - DexCom ile stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Tek bir belge ile KYC i\u015flemini dakikalar i\u00e7inde tamamlay\u0131n, g\u00fcnler de\u011fil<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - T\u0131bbi teknoloji hisselerinde yeni olanlar i\u00e7in sezgisel aray\u00fcz<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, DexCom gibi yenilik\u00e7i sa\u011fl\u0131k \u015firketlerine maruz kalmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in riski uygun \u015fekilde y\u00f6netirken \u00f6zellikle uygundur.<\/p>  <h2>\ud83c\udf0d 2025'te DexCom: Diyabet Teknolojisi Lideri<\/h2> <p>DexCom, devrim niteli\u011findeki G7 sistemleriyle s\u00fcrekli glikoz izleme pazar\u0131nda lider konumdad\u0131r. \u015eirketin 15 g\u00fcnl\u00fck giyilebilir cihaz\u0131 i\u00e7in yak\u0131n zamanda ald\u0131\u011f\u0131 FDA onay\u0131, mevcut en uzun \u00f6m\u00fcrl\u00fc ve en do\u011fru CGM sistemini temsil ediyor<a href=\"https:\/\/investors.dexcom.com\/news\/news-details\/2025\/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System\/default.aspx\">DexCom Haberleri<\/a>. 1.083'ten fazla kurumsal yat\u0131r\u0131mc\u0131n\u0131n pozisyonu ve 4,60 milyar $ gelirle g\u00fc\u00e7l\u00fc finansal sa\u011fl\u0131k g\u00f6steren DexCom, 2035'te 55 milyar $'a ula\u015fmas\u0131 beklenen pazarda liderli\u011fini s\u00fcrd\u00fcr\u00fcyor.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda DexCom'un ara\u015ft\u0131rma ekibi, CGM sens\u00f6rlerinin geleneksel parmak ucu testlerinden 45 dakika \u00f6ncesine kadar kan \u015fekeri trendlerini tespit edebildi\u011fini ke\u015ffetti; bu, diyabet y\u00f6netimi ve acil durum \u00f6nlemlerinde d\u00fcnya \u00e7ap\u0131nda devrim yaratabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 DexCom Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, DexCom, Inc. (DXCM) NASDAQ borsas\u0131nda <strong>80,90 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>23 Ekim 2025<\/strong> kesinlikle kritik &#8211; DexCom, piyasa kapan\u0131\u015f\u0131ndan sonra bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak.<\/p>\n<p>\u015eirket, 30 Temmuz&#8217;da g\u00fc\u00e7l\u00fc 2025 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 bildirdi; gelir y\u0131ll\u0131k %15 art\u0131\u015fla 1,16 milyar $&#8217;a y\u00fckseldi ve beklentileri 0,03 $ a\u015fan 0,48 $ hisse ba\u015f\u0131 kazan\u00e7 (EPS) a\u00e7\u0131klad\u0131. Tarihsel olarak, bu kazan\u00e7 raporlar\u0131 \u00f6nemli fiyat hareketlerine neden olur.<\/p>\n<p><strong>Kazan\u00e7 Raporlar\u0131 Genellikle DXCM Hissesini Nas\u0131l Etkiler:<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>78,50 $<\/td>\n<td>%3,1 Art\u0131\u015f (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>30 Nis 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>75,20 $<\/td>\n<td>%6,8 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>31 Oca 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>72,80 $<\/td>\n<td>%4,2 Art\u0131\u015f (g\u00fc\u00e7l\u00fc rehberlik)<\/td>\n<\/tr>\n<tr>\n<td>24 Eki 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>68,90 $<\/td>\n<td>%2,1 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>25 Tem 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>65,40 $<\/td>\n<td>%5,3 Art\u0131\u015f (\u00fcr\u00fcn lansman\u0131)<\/td>\n<\/tr>\n<tr>\n<td>25 Nis 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>62,10 $<\/td>\n<td>%8,7 Art\u0131\u015f (FDA onay haberi)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle DXCM&#8217;yi bir hafta i\u00e7inde %5-8 oran\u0131nda y\u00fckseltirken, beklentilerin alt\u0131nda kalan sonu\u00e7lar k\u0131sa vadede %2-3 d\u00fc\u015f\u00fc\u015fe neden olur. Hisse, pazar liderli\u011fi konumu nedeniyle g\u00fc\u00e7l\u00fc dayan\u0131kl\u0131l\u0131k ve h\u0131zl\u0131 toparlanma e\u011filimleri g\u00f6stermi\u015ftir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>DexCom hisseleri son alt\u0131 ayda etkileyici volatilite ve b\u00fcy\u00fcme g\u00f6sterdi:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 72,50 $ (tatil sonras\u0131 konsolidasyon)<br \/> <strong>Mart 2025<\/strong>: 76,80 $ (G7 15 G\u00fcnl\u00fck FDA onay\u0131 beklentisi)<br \/> <strong>Nisan 2025<\/strong>: 79,20 $ (1. \u00e7eyrek kazan\u00e7lar\u0131 a\u015f\u0131m\u0131 + rehberlik y\u00fckseltmesi)<br \/> <strong>May\u0131s 2025<\/strong>: 81,50 $ (kurumsal birikim d\u00f6nemi)<br \/> <strong>Haziran 2025<\/strong>: 77,30 $ (piyasa genelinde teknoloji sekt\u00f6r\u00fc d\u00fczeltmesi)<br \/> <strong>Temmuz 2025<\/strong>: 82,40 $ (g\u00fc\u00e7l\u00fc 2. \u00e7eyrek sonu\u00e7lar\u0131 + tam y\u0131l rehberli\u011fi y\u00fckseltildi)<br \/> <strong>A\u011fustos 2025<\/strong>: 80,90 $ (mevcut seviye, kazan\u00e7 sonras\u0131 konsolidasyon)<\/p>\n<p>Hisse bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%11,6<\/strong> de\u011fer kazand\u0131 ve bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fc rakibini \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. Bu b\u00fcy\u00fcme, ba\u015far\u0131l\u0131 \u00fcr\u00fcn lansmanlar\u0131, geni\u015fleyen sigorta kapsam\u0131 ve artan k\u00fcresel diyabet prevalans\u0131 gibi bir\u00e7ok kataliz\u00f6r taraf\u0131ndan desteklendi.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve piyasa trendlerine dayanarak, beklenenler \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 95-105 $ (mevcut seviyelerden %23-30 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> Analistler ortalama 99,89 $ fiyat hedefi ile &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecesini koruyor, bu %23,48 potansiyel y\u00fckseli\u015fi temsil ediyor<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DXCM\/forecast\/\">MarketBeat<\/a><\/li>\n<li><strong>2026 Tahmini<\/strong>: 105-115 $ (%30-42 toplam kazan\u00e7)<br \/> Morgan Stanley&#8217;nin 89,00 $&#8217;a y\u00fckseltti\u011fi hedef, temkinli b\u00fcy\u00fcmeyi i\u015faret ederken di\u011fer analistler 100 $+ seviyelerini \u00f6ng\u00f6r\u00fcyor<a href=\"https:\/\/www.ainvest.com\/news\/dexcom-price-target-raised-morgan-stanley-89-00-maintains-equal-weight-rating-2507\/\">AInvest<\/a><\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 120-140 $ (%48-73 de\u011fer art\u0131\u015f\u0131)<br \/> K\u00fcresel diyabet salg\u0131n\u0131 ve geli\u015fmekte olan pazarlarda teknoloji benimsenmesi taraf\u0131ndan destekleniyor<\/li>\n<li><strong>2030 Uzun Vadeli<\/strong>: 150-180 $ (%85-122 toplam getiri)<br \/> CGM pazar\u0131n\u0131n 2035&#8217;e kadar 12,8 milyar dolardan 55 milyar dolara geni\u015flemesine dayan\u0131yor<a href=\"https:\/\/www.futuremarketinsights.com\/reports\/continuous-glucose-monitoring-systems-market\">Future Market Insights<\/a><\/li>\n<\/ul>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir<\/li>\n<li><strong>Rekabet yo\u011funlu\u011fu<\/strong>: Abbott&#8217;un FreeStyle Libre ve Medtronic sistemleri g\u00fc\u00e7l\u00fc rakiplerdir<\/li>\n<li><strong>Geri \u00f6deme de\u011fi\u015fiklikleri<\/strong>: Sigorta kapsam\u0131 politikalar\u0131 benimsenme oranlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiler<\/li>\n<li><strong>Y\u00fcksek de\u011ferleme<\/strong>: 56,51 P\/E oran\u0131 primli fiyatlamay\u0131 g\u00f6sterir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>%15 gelir b\u00fcy\u00fcmesi<\/strong>: 2025 2. \u00e7eyrek g\u00fc\u00e7l\u00fc geni\u015fleme g\u00f6sterdi<a href=\"https:\/\/stockinvest.us\/DXCM-stock-price\">StockInvest<\/a><\/li>\n<li><strong>Kurumsal birikim<\/strong>: Fox Run Management ve Corient IA pozisyonlar\u0131n\u0131 art\u0131r\u0131yor<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DXCM\/news\/\">MarketBeat Haberleri<\/a><\/li>\n<li><strong>Pazar liderli\u011fi<\/strong>: G7 15 G\u00fcnl\u00fck sistemi &#8220;en do\u011fru CGM&#8221; olarak FDA onay\u0131 ald\u0131<a href=\"https:\/\/investors.dexcom.com\/news\/news-details\/2025\/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System\/default.aspx\">DexCom Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a><\/li>\n<li><strong>K\u00fcresel diyabet b\u00fcy\u00fcmesi<\/strong>: D\u00fcnya genelinde 537 milyon yeti\u015fkin diyabetli ve bu say\u0131 her y\u0131l art\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 temsil etmeyen pozisyonlarla ba\u015flay\u0131n<\/li>\n<li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: Toplu al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 23 Ekim kazan\u00e7 tarihi \u00e7evresinde fiyat hareketlerini takip edin<\/li>\n<li><strong>Uygun \u015fekilde \u00e7e\u015fitlendirin<\/strong>: DXCM, di\u011fer sa\u011fl\u0131k ve teknoloji hisseleriyle dengelenmeli<\/li>\n<\/ol>\n<p>Esprili yat\u0131r\u0131mc\u0131 bilgeli\u011fi: &#8220;DXCM ticareti yapmak, diyabeti y\u00f6netmek gibidir &#8211; s\u00fcrekli izleme ve ara s\u0131ra d\u00fczeltmeler gerekir, ancak uzun vadeli trend kesinlikle tatl\u0131d\u0131r!&#8221;<\/p>\n<h2>\u2705 DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve temel finansal bilgi ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;DXCM&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;DexCom&#8221; de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri giri\u015f fiyat\u0131n\u0131 kontrol etmeye yard\u0131mc\u0131 olur, piyasa emirlerine kar\u015f\u0131<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti onaylamadan \u00f6nce kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>Pozisyonu izleyin ve uygun stop-loss seviyeleri belirleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Performans\u0131 takip edin<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131n\u0131 kullan\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni DXCM Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, DXCM hisseleri ticareti konusunda birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; DexCom ile stratejileri \u00f6nemli risk olmadan test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Tek bir belge ile KYC i\u015flemini dakikalar i\u00e7inde tamamlay\u0131n, g\u00fcnler de\u011fil<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; T\u0131bbi teknoloji hisselerinde yeni olanlar i\u00e7in sezgisel aray\u00fcz<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, DexCom gibi yenilik\u00e7i sa\u011fl\u0131k \u015firketlerine maruz kalmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in riski uygun \u015fekilde y\u00f6netirken \u00f6zellikle uygundur.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te DexCom: Diyabet Teknolojisi Lideri<\/h2>\n<p>DexCom, devrim niteli\u011findeki G7 sistemleriyle s\u00fcrekli glikoz izleme pazar\u0131nda lider konumdad\u0131r. \u015eirketin 15 g\u00fcnl\u00fck giyilebilir cihaz\u0131 i\u00e7in yak\u0131n zamanda ald\u0131\u011f\u0131 FDA onay\u0131, mevcut en uzun \u00f6m\u00fcrl\u00fc ve en do\u011fru CGM sistemini temsil ediyor<a href=\"https:\/\/investors.dexcom.com\/news\/news-details\/2025\/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System\/default.aspx\">DexCom Haberleri<\/a>. 1.083&#8217;ten fazla kurumsal yat\u0131r\u0131mc\u0131n\u0131n pozisyonu ve 4,60 milyar $ gelirle g\u00fc\u00e7l\u00fc finansal sa\u011fl\u0131k g\u00f6steren DexCom, 2035&#8217;te 55 milyar $&#8217;a ula\u015fmas\u0131 beklenen pazarda liderli\u011fini s\u00fcrd\u00fcr\u00fcyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda DexCom&#8217;un ara\u015ft\u0131rma ekibi, CGM sens\u00f6rlerinin geleneksel parmak ucu testlerinden 45 dakika \u00f6ncesine kadar kan \u015fekeri trendlerini tespit edebildi\u011fini ke\u015ffetti; bu, diyabet y\u00f6netimi ve acil durum \u00f6nlemlerinde d\u00fcnya \u00e7ap\u0131nda devrim yaratabilir.<\/p>\n"},"faq":[{"question":"DexCom hisseleri nereden al\u0131nabilir?","answer":"DexCom hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"DexCom hissesi almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir ancak Pocket Option gibi platformlarda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"DexCom hisselerinin 2025 sonu fiyat tahmini nedir?","answer":"Analistlerin ortalama tahminine g\u00f6re 2025 sonunda DexCom hisseleri 95-105 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir."},{"question":"DexCom hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcz\u00fc portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'i ile s\u0131n\u0131rlay\u0131n, kazan\u00e7 raporlar\u0131 \u00f6ncesi fiyat hareketlerini takip edin ve \u00e7e\u015fitlendirmeye \u00f6nem verin."},{"question":"DexCom'un rekabet avantajlar\u0131 nelerdir?","answer":"DexCom, FDA onayl\u0131 en uzun \u00f6m\u00fcrl\u00fc ve en do\u011fru s\u00fcrekli glikoz izleme sistemine sahip olup, g\u00fc\u00e7l\u00fc kurumsal yat\u0131r\u0131mc\u0131 deste\u011fi ve b\u00fcy\u00fcyen k\u00fcresel diyabet pazar\u0131nda lider konumdad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"DexCom hisseleri nereden al\u0131nabilir?","answer":"DexCom hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"DexCom hissesi almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir ancak Pocket Option gibi platformlarda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"DexCom hisselerinin 2025 sonu fiyat tahmini nedir?","answer":"Analistlerin ortalama tahminine g\u00f6re 2025 sonunda DexCom hisseleri 95-105 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir."},{"question":"DexCom hissesi al\u0131rken nelere dikkat etmeliyim?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcz\u00fc portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'i ile s\u0131n\u0131rlay\u0131n, kazan\u00e7 raporlar\u0131 \u00f6ncesi fiyat hareketlerini takip edin ve \u00e7e\u015fitlendirmeye \u00f6nem verin."},{"question":"DexCom'un rekabet avantajlar\u0131 nelerdir?","answer":"DexCom, FDA onayl\u0131 en uzun \u00f6m\u00fcrl\u00fc ve en do\u011fru s\u00fcrekli glikoz izleme sistemine sahip olup, g\u00fc\u00e7l\u00fc kurumsal yat\u0131r\u0131mc\u0131 deste\u011fi ve b\u00fcy\u00fcyen k\u00fcresel diyabet pazar\u0131nda lider konumdad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T13:47:59+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T13:47:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\",\"name\":\"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-20T13:47:59+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/","og_locale":"tr_TR","og_type":"article","og_title":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T13:47:59+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T13:47:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/","name":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-20T13:47:59+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dexcom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"DexCom, Inc. (DXCM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; DexCom, Inc. (DXCM) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":341028,"slug":"how-to-buy-dexcom","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu DexCom, Inc. (DXCM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu DexCom, Inc. (DXCM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-dexcom\/"},"pt_AA":{"locale":"pt_AA","id":341025,"slug":"how-to-buy-dexcom","post_title":"Como comprar a\u00e7\u00f5es da DexCom, Inc. (DXCM) - Investimento em a\u00e7\u00f5es da DexCom, Inc. (DXCM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-dexcom\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=341024"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341024\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=341024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=341024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=341024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}